Provocative poster sessions abound at the SPD 2022 47th Annual Meeting
You will find dermatologic studies from the rare (annual erythema of infancy) to the common (atopic dermatitis) and lots in between at the poster sessions at this year's SPD 2022 47th Annual Meeting in Indianapolis, Indiana.
Dermatology experts that span the United States, Germany, France, and elsewhere offer exciting and novel poster sessions at this year's medical conference.
During these sessions, you can discover a number of studies on the burden of atopic dermatitis in infants and preschoolers; an algorithm approach to identify teenagers with hidradenitis suppurativa at risk for poor school performance; investigations of Crohn's disease in pyoderma gangrenosum management, and drug reactions among pediatric allogeneic hematopoietic stem call transplantation patients.
Pediatric teledermatology in rural Malawi, an analysis of pediatric lichen nitidus, systematic review of mental health comorbidties in juvenile localized scleroderma, and even a look at a pilot randomized controlled trial on the effect of virtual reality on pain and anxiety levels during dermatologic procedures are also on view.
The sessions span themes of what's new in biologics, psychosocial concerns in dermatology for children and adolescents, and both rare and common dermatologic disorders in the pediatric population.
The robust number of available poster sessions point to just how busy a year it has been in the field of pediatric dermatology.
Lawrence Eichenfield, MD, talks tapinarof cream, 1%, nemolizumab FDA approvals for atopic dermatitis
December 20th 2024"Tapinarof comes in with that mixture of the short-term studies and longer-term studies intermittently, giving us a nice, effective alternative non-steroid for eczema across the ages."
Recognize & Refer: Hemangiomas in pediatrics
July 17th 2019Contemporary Pediatrics sits down exclusively with Sheila Fallon Friedlander, MD, a professor dermatology and pediatrics, to discuss the one key condition for which she believes community pediatricians should be especially aware-hemangiomas.
